AG
ABMD

AIA Group’s Abiomed Inc ABMD Stock Holding History

AIA Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,723
Closed -$1.41M – 436
2022
Q3 		$1.41M Sell
5,723
-139
-2% -$37.5K 0.09% 93
2022
Q2 		$1.45M Sell
5,862
-889
-13% -$240K 0.08% 113
2022
Q1 		$2.24M Sell
6,751
-10,108
-60% -$3.11M 0.1% 96
2021
Q4 		$6.05M Buy
16,859
+1,898
+13% +$641K 0.29% 51
2021
Q3 		$4.87M Buy
14,961
+2,904
+24% +$984K 0.28% 60
2021
Q2 		$3.79M Buy
12,057
+1,314
+12% +$403K 0.26% 59
2021
Q1 		$3.42M Buy
10,743
+3,618
+51% +$1.16M 0.49% 51
2020
Q4 		$2.32M Buy
+7,125
New +$1.97M 0.27% 55

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AIA Group's ABMD Position: Q4 2022 in Review

AIA Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,723 shares — an estimated $1.41M sold.

AIA Group first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $6.05M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • AIA Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • AIA Group sold 5,723 Abiomed Inc shares in Q4 2022, an estimated $1.41M.
  • AIA Group first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • AIA Group's Abiomed Inc position peaked at $6.05M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AIA Group's 13F filing for Q4 2022, filed 31 Jan 2023.